IS4081A - Aðferð við framleiðslu efnasamsetninga - Google Patents
Aðferð við framleiðslu efnasamsetningaInfo
- Publication number
- IS4081A IS4081A IS4081A IS4081A IS4081A IS 4081 A IS4081 A IS 4081A IS 4081 A IS4081 A IS 4081A IS 4081 A IS4081 A IS 4081A IS 4081 A IS4081 A IS 4081A
- Authority
- IS
- Iceland
- Prior art keywords
- preparation
- chemical compositions
- compositions
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929221761A GB9221761D0 (en) | 1992-10-16 | 1992-10-16 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4081A true IS4081A (is) | 1994-04-17 |
Family
ID=10723562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4081A IS4081A (is) | 1992-10-16 | 1993-10-11 | Aðferð við framleiðslu efnasamsetninga |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5494910A (is) |
| EP (1) | EP0664804A1 (is) |
| JP (1) | JPH06211842A (is) |
| KR (1) | KR940009179A (is) |
| CN (1) | CN1092420A (is) |
| AP (1) | AP425A (is) |
| AU (1) | AU5333794A (is) |
| CA (1) | CA2146569A1 (is) |
| CZ (1) | CZ96895A3 (is) |
| EC (1) | ECSP941050A (is) |
| FI (1) | FI951798A0 (is) |
| GB (1) | GB9221761D0 (is) |
| HU (1) | HUT72752A (is) |
| IL (1) | IL107302A0 (is) |
| IS (1) | IS4081A (is) |
| MX (1) | MX9306394A (is) |
| NO (1) | NO951433D0 (is) |
| PE (1) | PE51294A1 (is) |
| PL (1) | PL308357A1 (is) |
| RU (1) | RU95110110A (is) |
| SI (1) | SI9300542A (is) |
| TW (1) | TW262473B (is) |
| WO (1) | WO1994008993A1 (is) |
| ZA (1) | ZA937633B (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) * | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| AU694226B2 (en) * | 1994-05-19 | 1998-07-16 | Merck Sharp & Dohme Limited | Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists |
| GB9610979D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| JP2001501946A (ja) * | 1996-10-08 | 2001-02-13 | イーライ・リリー・アンド・カンパニー | 新規セロトニン５―ｈｔ▲下１ｆ▼アゴニスト |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
| US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| PL2734634T3 (pl) | 2011-07-22 | 2020-03-31 | The University Of Chicago | Igf-1 do zastosowania do leczenia migreny |
| KR101443041B1 (ko) * | 2013-05-06 | 2014-09-23 | (주)하이레벤 | 태양광 발전설비의 효율향상설비 |
| JP2024531229A (ja) | 2021-08-12 | 2024-08-29 | クレオン リミティド ライアビリティ カンパニー | 幻覚誘発性及び非幻覚誘発性セロトニン受容体アゴニストならびにそれを作製する方法及び使用する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
-
1992
- 1992-10-16 GB GB929221761A patent/GB9221761D0/en active Pending
-
1993
- 1993-10-11 IS IS4081A patent/IS4081A/is unknown
- 1993-10-14 PL PL93308357A patent/PL308357A1/xx unknown
- 1993-10-14 EP EP93923463A patent/EP0664804A1/en not_active Withdrawn
- 1993-10-14 WO PCT/EP1993/002833 patent/WO1994008993A1/en not_active Application Discontinuation
- 1993-10-14 MX MX9306394A patent/MX9306394A/es unknown
- 1993-10-14 HU HU9501073A patent/HUT72752A/hu unknown
- 1993-10-14 CZ CZ95968A patent/CZ96895A3/cs unknown
- 1993-10-14 AU AU53337/94A patent/AU5333794A/en not_active Abandoned
- 1993-10-14 US US08/406,981 patent/US5494910A/en not_active Expired - Fee Related
- 1993-10-14 CA CA002146569A patent/CA2146569A1/en not_active Abandoned
- 1993-10-14 ZA ZA937633A patent/ZA937633B/xx unknown
- 1993-10-14 KR KR1019930021263A patent/KR940009179A/ko not_active Application Discontinuation
- 1993-10-14 RU RU95110110/04A patent/RU95110110A/ru unknown
- 1993-10-15 SI SI9300542A patent/SI9300542A/sl unknown
- 1993-10-15 AP APAP/P/1993/000581A patent/AP425A/en active
- 1993-10-15 CN CN93115016A patent/CN1092420A/zh active Pending
- 1993-10-15 IL IL107302A patent/IL107302A0/xx unknown
- 1993-10-15 JP JP5258631A patent/JPH06211842A/ja active Pending
- 1993-11-04 TW TW082108174A patent/TW262473B/zh active
-
1994
- 1994-03-02 EC EC1994001050A patent/ECSP941050A/es unknown
- 1994-04-13 PE PE1994240029A patent/PE51294A1/es not_active Application Discontinuation
-
1995
- 1995-04-12 NO NO951433A patent/NO951433D0/no unknown
- 1995-04-13 FI FI951798A patent/FI951798A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP9300581A0 (en) | 1993-10-31 |
| SI9300542A (en) | 1994-06-30 |
| TW262473B (is) | 1995-11-11 |
| FI951798A (fi) | 1995-04-13 |
| CZ96895A3 (en) | 1995-12-13 |
| EP0664804A1 (en) | 1995-08-02 |
| HU9501073D0 (en) | 1995-06-28 |
| CN1092420A (zh) | 1994-09-21 |
| ZA937633B (en) | 1994-08-01 |
| RU95110110A (ru) | 1996-12-27 |
| MX9306394A (es) | 1994-05-31 |
| PL308357A1 (en) | 1995-07-24 |
| KR940009179A (ko) | 1994-05-20 |
| FI951798A0 (fi) | 1995-04-13 |
| IL107302A0 (en) | 1994-01-25 |
| GB9221761D0 (en) | 1992-12-02 |
| PE51294A1 (es) | 1995-01-06 |
| CA2146569A1 (en) | 1994-04-28 |
| AU5333794A (en) | 1994-05-09 |
| HUT72752A (en) | 1996-05-28 |
| US5494910A (en) | 1996-02-27 |
| NO951433L (no) | 1995-04-12 |
| ECSP941050A (es) | 1994-11-16 |
| JPH06211842A (ja) | 1994-08-02 |
| AP425A (en) | 1995-11-08 |
| NO951433D0 (no) | 1995-04-12 |
| WO1994008993A1 (en) | 1994-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945441A0 (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi | |
| PT86974A (pt) | Process for the preparation of imidazol compounds and of biociddal compositions containing the same | |
| FI940769A (fi) | Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi | |
| FI935791A (fi) | Menetelmä polyhydroksikarboksyylihapon valmistamiseksi | |
| ITMI921552A0 (it) | Procedimento per la preparazione di glicerofosfolipidi | |
| IS4081A (is) | Aðferð við framleiðslu efnasamsetninga | |
| NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
| ITMI931680A1 (it) | Procedimento per la preparazione di alcansolfonammidi | |
| NO941056L (no) | Fremgangsmåte for fremstilling av organoklorsilaner | |
| DK0648738T3 (da) | Fremgangsmåde til fremstilling af acetoacetarylamider | |
| FI952134A0 (fi) | Menetelmä alkyykibentseenin valmistamiseksi | |
| NO179101C (no) | Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol | |
| NO305910B1 (no) | Fremgangsmåte for framstilling av alkyl-halosilaner | |
| NO304883B1 (no) | FremgangsmÕte ved fremstilling av hydrazin-nitroform | |
| FI961178A0 (fi) | Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi | |
| FI91069B (fi) | Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi | |
| FI960526A (fi) | Menetelmä kumeenihydroperoksin valmistamiseksi | |
| NO173871C (no) | Fremgangsmaate for fremstilling av penemforbindelser | |
| FI943660A0 (fi) | Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi | |
| FI102841B (fi) | Menetelmä mannitolin valmistamiseksi | |
| FI951723A (fi) | Menetelmä puhtaan podofyllotoksiinin valmistamiseksi | |
| DK0569701T3 (da) | Fremgangsmåde til fremstilling af 2-amino-5-methyl-pyridin | |
| NO174196C (no) | Fremgangsmåte for fremstilling av omega-decenol | |
| IS4086A (is) | Aðferð við framleiðslu efnasambanda | |
| DK0599044T3 (da) | Fremgangsmåde til fremstilling af chlorphenylphosphaner |